Pages
Tier 3 Weight Management for Professionals
The information here is for professionals in Derbyshire seeking more information on the Tier 3 Weight Management service.
New recycling arrangements explained
New recycling arrangements explained 2025
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/new-recycling-arrangements-explained
Cardiac rehabilitation services
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/cardiac-rehabilitation-services
Podiatric surgery
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/podiatric-surgery
Metal shell of new NHS facility in Chesterfield takes shape ahead of installation
https://dchs.nhs.uk/news/metal-shell-new-nhs-facility-chesterfield-takes-shape-ahead-installation
Button
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc a augue nisi. Integer sed lectus vel lorem sagittis blandit ut eu leo. Quisque nec elit massa. Interdum et malesuada fames ac ante ipsum primis in faucibus. Proin imperdiet sollicitudin risus, ut ornare nulla finibus nec. Aliquam sagittis turpis vulputate, lobortis mi vehicula, ultrices magna. Mauris augue augue, viverra in volutpat quis, imperdiet nec est. Ut in turpis ex. Pellentesque semper interdum aliquam. Cras consectetur mi tellus, eu tincidunt erat tincidunt in.
Files
Conservative Sharp Debridement (CSD) of Wounds Policy (P99)
We know that wound dressings should provide the optimal environment for wound healing after careful clinical assessment of the wound, the patient clinical condition and clinical outcomes. Hard to heal wounds, however, fail to progress, and many can be seen with dead tissue, slough and necrosis which in turn can increase the risk of infection and also increase cost within appropriate dressing use and nursing time. This procedure will only be undertaken by the Tissue Viability team members who have successfully completed a validated programme of care and assessment of competence in practice. A minimum of 10 episodes of observed practice is to be completed until competency can be granted. The purpose of debridement describes any method by which such materials (necrosis, slough and dead de-vascularised tissue) are removed and consequently the potential to achieve wound healing enhanced. It also reduces the bacterial load and minimises the risk of local and systemic infection. It can allow for wound draining and reduce odour overall enhancing patient quality of life.
Patient Experience Team leaflet
Patient experience team leaflet, includes information on how to make a complaint and where patients/carers can access support. Updated 2022
Disclosure Ref 2022124 - Staffing systems used.pdf
Response to FOI regarding Staffing systems used
Request for Temporary Electronic Prescribing Access for Agency Non-Medical Prescribers (A6 P57)
Request for Temporary Electronic Prescribing Access for Agency Non-Medical Prescribers For agency staff with a current and unrestricted independent NMP qualification who require temporary access to prescribing on SystmOne in order to maintain services. Requests must be authorised by both the service manager and DCHS Chief Pharmacist.
Disclosure Ref 2024176 - Spend on office supplies.pdf
FOI Disclosure Ref 2024176 relating to Spend on office supplies
Disclosure Ref 202514 - PIFU and virtual wards.pdf
Disclosure to freedom of information request regarding Virtual wards
Disclosure Ref 202535 - Document management systems.pdf
Disclosure to freedom of information request regarding Document management systems
Disclosure Ref 202572 - Lone worker Apps.pdf
Freedom of information disclosure Ref 202572 relating to lone worker devices and apps used and the contract for these
Disclosure Ref 202557 - Staff hired in a diversity, equality, equity or inclusion role.pdf
Freedom of information disclosure Ref 202557 relating to staff hired in a diversity, equality, equity or inclusion role
Disclosure Ref 2025125 - Mental Health Services 2 of 2 UNIFORM AND DRESS CODE POLICY.pdf
FOI disclosure Ref 2025125 - Mental Health Services (2 of 2) A copy of the UNIFORM AND DRESS CODE POLICY in answer to question 4 of the disclosure